Infectious Disease Movement in a Borderless World Workshop Summary (2010) / Chapter Skim
Currently Skimming:
Appendix D: Forum Member Biographies
Appendix D: Forum Member Biographies
Pages 281-302
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 281... ...
He completed his residency in internal medicine and a clinical fellowship in infectious diseases at Massachusetts General Hospital, Boston, after which he moved to Stanford for a postdoctoral fellowship in 1986 and joined the faculty there in 1994. His research focus is on understanding the structure and role of the human indigenous microbial communities in health and disease.
|
From page 282... ...
in 2001, the Senior Scholar Award in Global Infectious Diseases from the Ellison Medical Foundation in 2002, an NIH Director's Pioneer Award in 2006, and a Doris Duke Distinguished Clinical Scientist Award in 2006. He is also a fellow of the American Academy of Microbiology.
|
From page 283... ...
Dr. Acheson has published extensively and is internationally recognized both for his public health expertise in food safety and for his research in infectious diseases.
|
From page 284... ...
Since 2004 he has been chief executive officer of Centaur Science Group, which provides consulting services in biodefense. His main commitment is to the Defense Threat Reduction Agency's Biological Weapons Proliferation Prevention Program in Europe, the Caucasus, and Central Asia.
|
From page 285... ...
Gail H Cassell, Ph.D., is currently vice president, Scientific Affairs, and Distinguished Lilly Research Scholar for Infectious Diseases, Eli Lilly and Com pany, in Indianapolis, Indiana.
|
From page 286... ...
Currently she is a member of the Executive Committee of the Board of Visitors of Columbia University School of Medicine, the Board of Directors of the Burroughs Wellcome Fund, and the Advisory Council of the School of Nursing of Johns Hopkins. Mark Feinberg, M.D., Ph.D., is vice president for medical affairs and policy in global vaccine and infectious diseases at Merck & Co., Inc., and is responsible for global efforts to implement vaccines to achieve the greatest health benefits, including efforts to expand access to new vaccines in the developing world.
|
From page 287... ...
Feinberg and colleagues were engaged in the preclinical development and evaluation of novel vaccines for HIV and other infectious diseases and in basic research studies focused on revealing fundamental aspects of the pathogenesis of AIDS.
|
From page 288... ...
Captain Galloway began his Navy career at the Naval Medical Research Institute in Bethesda, Maryland, where he served as a research scientist working on vaccine development from 1980 to 1984. In late 1984, Captain Galloway left active service to pursue an academic appointment at Ohio State University, where he is now a tenured faculty member in the Department of Microbiology.
|
From page 289... ...
He is editor of the book Tick Borne Diseases of Humans published by ASM Press in 2005, and is a staff physician and infectious diseases consultant at the NIH Clinical Center and the National Naval Medical Center-Walter Reed Army Medical Center, as well as adjunct pro fessor of medicine at the University of Minnesota. He is active in a wide variety of clinical, public health, and product development issues, including pandemic and emerging infectious disease threats; bioterrorism preparedness and response; and blood, tissue, and vaccine safety and availability.
|
From page 290... ...
Recent honors and awards include being named an honorary member of the American Society of Tropical Medicine and Hygiene in 2002, an associate member of the National Academy of Medicine in 2002, an honorary member of the Society of Internal Medicine in 2000, and a distinguished visitor at the Faculty of Medical Sciences, University of Cordoba, Argentina, in 1999. In 1988 he received the Golden Medal for Outstanding Contribution in the Field of Infectious Diseases awarded by Trnava University, Slovakia.
|
From page 291... ...
As director of DMID she has responsibility for scientific direction, oversight, and management of all extramural research programs on infectious diseases (except AIDS) within NIH.
|
From page 292... ...
Dr. Heymann has been visiting professor at Stanford University, the University of Southern California, and the George Washington University School of Public Health; has published over 145 scientific articles on infectious diseases and related issues in peer-reviewed medical and scientific journals; and has authored several chapters on infectious diseases in medical textbooks.
|
From page 293... ...
Hughes' career has been on building partnerships among the clini cal, research, public health, and veterinary communities to prevent and respond to infectious diseases at the national and global levels. His research interests include emerging and reemerging infectious diseases; antimicrobial resistance; foodborne diseases; health-care-associated infections; vector-borne and zoonotic diseases; rapid detection of and response to infectious diseases and bioterrorism; strengthening public health capacity at the local, national, and global levels; and prevention of water-related diseases in the developing world.
|
From page 294... ...
Sinai School of Medicine in 1970, where he established a laboratory to study the pathogenesis of bacillary dysentery and the biology and biochemistry of Shiga toxin. In 1979 he moved to Tufts Medical School and New England Medical Center in Boston to found the Division of Geographic Medicine, which focused on the molecular and cellular biology of tropical infectious diseases.
|
From page 295... ...
She trained in internal medicine and completed a fellowship in infectious dis eases at the University of Maryland in Baltimore. She is also a clinical associate professor of medicine (infectious diseases)
|
From page 296... ...
He was cochair of the NAS Committee on Advances in Technology and the Prevention of Their Application to Next Generation Biowarfare Threats, and he recently chaired an IOM study committee related to vaccines for the protection of the military against naturally occurring infectious disease threats. Edward McSweegan, Ph.D., is a program officer at NIAID.
|
From page 297... ...
. He was a founding section editor of the CDC journal Emerging Infectious Diseases and was formerly an editor-in-chief of the Pasteur Institute's journal Research in Virology.
|
From page 298... ...
He served as principal investigator for the CDC-sponsored Emerging Infections Program in Minnesota. He has published more than 300 articles and abstracts on various emerging infectious disease problems and is the author of the best-selling book Living Terrors: What America Needs to Know to Survive the Coming Bioterrorist Catastrophe.
|
From page 299... ...
He served his residency at the Northwestern University School of Medicine and his infectious diseases fellowship at the Uni versity of Cincinnati School of Medicine. He is program director for infectious diseases for the Department of Veterans Affairs Central Office in Washington, DC, as well as the chief of the medical service at the Cincinnati VA Medical Center.
|
From page 300... ...
He was president of the Infectious Diseases Society of America from 1996 to 1997. He was also a member of the IOM Committee on Microbial Threats to Health (1990-1992)
|
From page 301... ...
Currently, Dr. Trostle leads the USAID Infectious Disease Surveillance Initiative as well as the Avian Influenza Unit.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.